The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Drugmaker Novo Nordisk is taking action to curb the massively popular compounded semaglutide industry, which provides copies of its blockbuster weight-loss drugs Ozempic and Wegovy to patients—often for much lower …